Table 1 The number of OTUs with significantly different abundances in each antibiotic treatment compared to the control group.

From: Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients

Body site

3GC

TZP

Higher

Lower

Higher

Lower

Endotracheal

12

73

3

54

Perineal

6

2

54

3

Faecal

17

48

21

34

  1. Data obtained through LEfSe analyses between the relative abundance of bacterial OTUs in each antibiotic treatment (3GC-third-generation cephalosporins, TZP-piperacillin/tazobactam) and control group (no β-lactams) for each body site.
Back to article page